Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Annovis Bio Inc
07XCurrent price
6.92 EUR
0 EUR (0.00%)
Last closed
7.54 USD
Company
www.annovisbio.com
ISIN
US03615A1088
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
106 520 640 USD
Yield for 12 month
+16.75 %
1Y
3Y
5Y
10Y
15Y
07X
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which has completed three Phase 1/2 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405, which is in Phase 2 and Phase 3 efficacy studies, an intravenous drug for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials, an orally administered drug to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Malvern, Pennsylvania. Address: 101 Lindenwood Drive, Malvern, PA, United States, 19355
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
34.8 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures 07X
1 year
3 years
5 years
10 years
EBITDA
–
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-154.58 %
PEG Ratio
–
Return On Equity TTM
-596.7 %
Wall Street Target Price
34.8 USD
Revenue TTM
–
Book Value
0.53 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-4.54 USD
Diluted Eps TTM
-4.54 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 07X
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 07X
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 07X
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-3.5651
Price Book MRQ
19.6801
Financials 07X
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 07X
For 52 weeks
4.79 USD
22.49 USD
50 Day MA
8.53 USD
Shares Short Prior Month
1 196 148
200 Day MA
9.04 USD
Short Ratio
5.96
Shares Short
1 358 798
Short Percent
13.27 %
BeatStart